Is physician profiling on its way out?
In the March 2002 issue, PharmaVOICE asked readers how proposed AMA guidelines, which would limit the use of physician prescribing profiles by pharmaceutical companies, would impact their marketing, research, and sales efforts?
Terry Nugent, Director of Marketing, Medical Marketing Service Inc. (MMS)
Education At Risk
Art Kolodkin, Senior VP, Business Development, Network for Continuing Medical Education
A Strategic Struggle
Neil H. Gray, Consultant, Healthcare Trends and Strategies
Trevor Deal, Sr. National Accounts Manager, Annals of Long Term Care
Loss of Control
Tony Goosmann, Executive VP, Williams-Labadie
A Warranted Concern
Chris Duncan, MBA, Marketing manager, Vical Inc.